BIOLIFE SOLUTIONS INC — Director's Dealing 2019

Dec 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2019-12-10

Reporting Person: Rice Michael (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-10	Common Stock	G	7000	—	Disposed	168014	Direct
2019-12-10	Common Stock	M	10000	$1.12	Acquired	178014	Direct
2019-12-10	Common Stock	S	10000	$15.37	Disposed	168014	Direct
2019-12-12	Common Stock	M	10247	$1.12	Acquired	178261	Direct
2019-12-12	Common Stock	S	10247	$15.11	Disposed	168014	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-10	Employee Stock Option	$1.12	M	10000	Disposed	2021-02-25	Common Stock (10000)	Direct
2019-12-12	Employee Stock Option	$1.12	M	10247	Disposed	2021-02-25	Common Stock (10247)	Direct

Footnotes

F1: This transaction represents a charitable donation to a third party. No value was received for the gifted shares.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.35 to $15.41, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.18, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: The reporting person's Form 4 filed on November 14, 2019 reported a remainder of 10,247 derivative securities when in fact the remainder was 20,247 derivative securities beneficially owned by the reporting person.